Clinical Trials Logo

Clinical Trial Summary

The study aimed at detection of autonomic dysfunction among cases with temporal lobe epilepsy; using different electrophysiological techniques. Moreover, it aimed at finding any correlation between electrophysiological tests and SUDEP risk.


Clinical Trial Description

Temporal lobe epilepsy (TLE) is the commonest focal form of epilepsy; representing 60% of all epilepsies . It has two major subtypes; neocortical (nTLE) and mesial (mTLE), each with different presentations. Its diagnosis depends on detailed clinical history, neurological examination as well as neurophysiological (including EEG), and neuroimaging diagnostic tests which are mandatory in localizing the pathology. Intimate connection between epileptic networks and the autonomic nervous system had been revealed. Seizures could affect autonomic functions whether directly through activation of cortical autonomic centers or indirectly through the released catecholamines. The SUDEP is considered as one of the most serious complications of epilepsy and second most common cause of death from neurological diseases after stroke. Autonomic dysfunction could have a potential role in the pathophysiology of sudden unexpected death of epileptic patients (SUDEP). Attention has been focused on biomarkers that could assist in the detection and early stratification of SUDEP risk. Such biomarkers include neurophysiological tests, imaging findings, laboratory findings. Among the introduced neurophysiological biomarkers are electroencephalogram (EEG), sympathetic skin response (SSR) and heart rate variability (HRV). The HRV is considered as simple, sensitive index of cardiovagal function. Reduced heart rate variability (HRV) is a strong predictor of sudden death in patients with heart disease. The electrodermal activity (EDA )or SSR is referred as the most popular used test for assessment the sudomotor function . The EDA had been proven to be a reliable biomarker for detecting generalized tonic-clonic seizures (GTCs) through a wearable device. Frontal midline theta activity was studied using quantitative EEG (QEEG); that confirmed the presence of interactive relationships between activities of the peripheral autonomic system and the cortical network. The QEEG technique had been introduced in the thirties of the last century. Yet, it had not been applied before on epileptic patients to assess either the central autonomic function or the SUDEP risk and thus, this is considered as the first study to address such issue. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06269822
Study type Observational
Source Cairo University
Contact
Status Completed
Phase
Start date September 1, 2022
Completion date January 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT05159609 - Closed Loop Auditory Stimulus in Sleep and epilepsY N/A
Completed NCT02946151 - Subcutaneous EEG in Epilepsy N/A
Not yet recruiting NCT02590419 - Application of Diffusion Tensor Imaging and Tractography in Epilepsy Surgery N/A
Completed NCT00595699 - Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy Phase 4
Recruiting NCT05609084 - Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy N/A
Completed NCT00344877 - Electrical Brain Stimulation to Reduce Epileptic Seizures N/A
Recruiting NCT03643471 - Advanced Magnetic Resonance Imaging in Temporal Lobe Epilepsy
Terminated NCT00717431 - A Multicenter Study of Hippocampal Electrical Stimulation (HS, in Mesial Temporal Lobe Epilepsy Phase 3
Not yet recruiting NCT05794295 - Sleep Architecture & Intrinsic Oscillatory and Network Connectivity in Cognition and Executive Dysfunction in TLE N/A
Completed NCT02844465 - Stereotactic Laser Ablation for Temporal Lobe Epilepsy N/A
Recruiting NCT05179083 - Exercise for Brain Regeneration in Epilepsy Phase 1
Recruiting NCT05019404 - Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy N/A